News

Researchers found that the Pediatric Psychiatry Colocalized Consult Clinic significantly reduces wait times and improves resident confidence.

FDA green-lights Imcivree for acquired hypothalamic obesity in patients 4 years and older, delivering major reductions in BMI and hunger in phase 3.

Aristides Maniatis, MD, FAAP explains how Sogroya reduces treatment burden and improves adherence for pediatric patients with growth disorders.

A recent study has reported increasing rates of self-injury up to 4.3% among youths, with girls showing higher rates than boys.

Integrating an automated tobacco treatment system into routine pediatric visits significantly increased smoking cessation rates among mothers.

A study found that cognitive and developmental advantages for firstborns appear within the first year of life.

The FDA sanctioned Johnson & Johnson’s once-daily oral pill for adults and adolescents with moderate to severe plaque psoriasis.

Pediatricians can use brief dietary screenings and policy advocacy to help families transition from ultra-processed foods toward minimally processed alternatives.

A study found that high consumption of ultra-processed foods in early childhood is associated with increased risks of anxiety, hyperactivity, and aggression.

After a decade of clinical assessments failed to meet DSM-5 criteria, a chromosomal microarray revealed the genetic truth behind a complex neurodevelopmental presentation.

Kara Margolis, MD, highlights how early life stress influences gastrointestinal health through the gut-brain axis.

The INTEGUMENT-OLE study results highlight the long-term efficacy and safety of roflumilast cream for pediatric patients with atopic dermatitis.

A phase 3 trial shows that lebrikizumab improves skin clearance and itch in infants and children with moderate to severe atopic dermatitis.

Get caught up with Contemporary Pediatrics. This list helps you navigate our top stories from the week, all in one place.

A study found children who experience a mild traumatic brain injury are more likely to develop new or chronic sleep problems vs typically developing children.

Secukinumab now treats moderate to severe hidradenitis suppurativa in patients 12 years and older, making it the first IL‑17A biologic option for teens.

A study found that prompt blood sugar control following a gestational diabetes diagnosis can reduce a child's risk of obesity.

A study found that day-to-day fluctuations in screen use have a minimal impact on subsequent sleep outcomes among children and adolescents.

Daniel Jaechul Ahn, MD, BS, explains how status exceptions are used to navigate the current 3-status system and why policy reform is necessary.

Researchers have found that reducing parental stress improves parenting behaviors and lowers obesity rates in children.

A study found that high consumption of ultra-processed foods in early childhood is associated with increased risks of anxiety, hyperactivity, and aggression.

Researchers emphasize that while generative AI offers new learning tools for youth, parents must actively supervise its use and prioritize human interaction.

A study found that AI-generated nutrition plans for adolescents undercalculate caloric needs by an average of 700 kcal and skew macronutrient ratios.

A study found that decreased mortality in children awaiting heart transplants is due to improved overall medical care rather than revisions to waitlist allocation rules.

Children with Crohn disease had reduced microbial diversity and increased proinflammatory bacteria vs peers with disorders of brain-gut interaction.

The approval marks the first treatment option for patients with this rare condition.

Mariana Bueno, PhD, RN, discusses the physiological considerations, clinical barriers, and best practices for effectively using sucrose to mitigate procedural pain in infants.

Universal smartphone use during school, specifically frequent checking, is associated with decreased inhibitory control and attentional resources in teens.